Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 26-May-22 5:26 PM View:  | Antares Pharma Inc. (ATRS) | 24-May-22 | Disposition | 170,575 | $5.60 | $955,220.00 | (100%) 170.57K to 0 | |
| 04-Feb-22 10:00 PM View: | Antares Pharma Inc. (ATRS) | 26-Oct-21 | Gift | 125,000 | -- | -- | (42%) 295.57K to 170.57K | |
| 31-Aug-21 6:26 PM View: | Antares Pharma Inc. (ATRS) | 27-Aug-21 | Grant | 24,679 | $2.24 | $55,281.00 | 9% 284.72K to 309.39K | |
| 31-Aug-21 6:26 PM View: | Antares Pharma Inc. (ATRS) | 27-Aug-21 | Payment of Exercise | 13,820 | $4.00 | $55,280.00 | (4%) 309.39K to 295.57K | |
| 14-Jun-21 6:24 PM View: | Antares Pharma Inc. (ATRS) | 10-Jun-21 | Grant | 31,674 | $4.42 | $139,999.00 | 13% 253.04K to 284.72K | < 1% |
| 19-Feb-21 7:08 PM View: | Antares Pharma Inc. (ATRS) | 18-Feb-21 | Option Exercise | 15,321 | $2.24 | $34,319.00 | 6% 253.04K to 268.36K | |
| 19-Feb-21 7:08 PM View: | Antares Pharma Inc. (ATRS) | 18-Feb-21 | Market Option Sale (Planned) | 15,321 | $5.05 | $77,371.10 | (6%) 268.36K to 253.04K | 24% |
| 15-Jun-20 7:05 PM View: | Antares Pharma Inc. (ATRS) | 11-Jun-20 | Grant | 40,293 | $2.73 | $110,000.00 | 19% 212.75K to 253.04K | 41% |
| 11-Dec-19 7:21 PM View: | Antares Pharma Inc. (ATRS) | 09-Dec-19 | Option Exercise | 160,000 | $1.63 | $260,800.00 | 54% 297.56K to 457.56K | |
| 11-Dec-19 7:21 PM View: | Antares Pharma Inc. (ATRS) | 09-Dec-19 | Market Option Sale | 160,000 | $4.63 | $740,575.00 | (35%) 457.56K to 297.56K | 17% |
| 11-Dec-19 7:21 PM View: | Antares Pharma Inc. (ATRS) | 09-Dec-19 | Market Sale | 84,814 | $4.63 | $392,570.00 | (29%) 297.56K to 212.75K | 17% |
| 04-Nov-19 6:59 AM View: | Antares Pharma Inc. (ATRS) | 31-Oct-19 | Option Exercise | 20,000 | $1.10 | $22,000.00 | 7% 277.56K to 297.56K | |
| 14-Jun-19 5:36 PM View: | Antares Pharma Inc. (ATRS) | 13-Jun-19 | Grant | 37,671 | $2.92 | $109,999.00 | 16% 239.89K to 277.56K | 32% |
| 10-Apr-19 5:49 PM View: | Antares Pharma Inc. (ATRS) | 08-Apr-19 | Option Exercise | 92,078 | $0.53 | $48,801.30 | 38% 239.89K to 331.97K | |
| 10-Apr-19 5:49 PM View: | Antares Pharma Inc. (ATRS) | 08-Apr-19 | Market Option Sale (Planned) | 92,078 | $3.00 | $276,243.00 | (28%) 331.97K to 239.89K | (29%) |
| 02-Apr-18 5:10 PM View: | Antares Pharma Inc. (ATRS) | 29-Mar-18 | Option Exercise | 32,407 | $0.85 | $27,546.00 | 16% 207.49K to 239.89K | |
| 11-Oct-17 5:56 PM View: | Antares Pharma Inc. (ATRS) | 09-Oct-17 | Option Exercise | 218,600 | $0.55 | $119,800.00 | 100% 218.88K to 437.49K | |
| 11-Oct-17 5:56 PM View: | Antares Pharma Inc. (ATRS) | 09-Oct-17 | Market Option Sale (Planned) | 218,600 | $4.05 | $885,729.00 | (50%) 437.49K to 218.88K | 5% |
| 11-Oct-17 5:56 PM View: | Antares Pharma Inc. (ATRS) | 09-Oct-17 | Market Sale (Planned) | 11,400 | $4.05 | $46,190.80 | (5%) 218.88K to 207.49K | 5% |
| 05-Apr-17 5:23 PM View: | Antares Pharma Inc. (ATRS) | 04-Apr-17 | Option Exercise | 21,762 | $1.65 | $35,907.30 | 10% 218.88K to 240.65K | |
| 05-Apr-17 5:23 PM View: | Antares Pharma Inc. (ATRS) | 04-Apr-17 | Market Option Sale (Planned) | 21,762 | $2.90 | $63,112.00 | (9%) 240.65K to 218.88K | (33%) |
| 05-Apr-17 5:23 PM View: | Antares Pharma Inc. (ATRS) | 03-Apr-17 | Option Exercise | 20,000 | $1.65 | $33,000.00 | 9% 218.88K to 238.88K | |
| 05-Apr-17 5:23 PM View: | Antares Pharma Inc. (ATRS) | 03-Apr-17 | Market Option Sale (Planned) | 20,000 | $2.88 | $57,570.00 | (8%) 238.88K to 218.88K | (34%) |
| 05-Dec-16 5:26 PM View: | Antares Pharma Inc. (ATRS) | 01-Dec-16 | Option Exercise | 20,000 | $1.23 | $24,600.00 | 9% 218.88K to 238.88K | |
| 05-Dec-16 5:26 PM View: | Antares Pharma Inc. (ATRS) | 01-Dec-16 | Market Option Sale (Planned) | 20,000 | $1.97 | $39,416.00 | (8%) 238.88K to 218.88K | (95%) |
| 21-Mar-16 9:12 AM View: | Antares Pharma Inc. (ATRS) | 18-Mar-16 | Market Purchase | 50,000 | $0.72 | $36,000.00 | 30% 168.88K to 218.88K | 455% |
| 24-Mar-15 4:30 PM View: | Antares Pharma Inc. (ATRS) | 23-Mar-15 | Market Sale | 19,100 | $2.68 | $51,188.00 | (10%) 187.99K to 168.88K | (48%) |
| 24-Mar-15 4:30 PM View: | Antares Pharma Inc. (ATRS) | 20-Mar-15 | Market Sale | 4,400 | $2.69 | $11,836.00 | (2%) 192.38K to 187.99K | (48%) |
| 12-Aug-14 5:17 PM View: | Antares Pharma Inc. (ATRS) | 11-Aug-14 | Market Purchase | 10,000 | $1.98 | $19,800.00 | 5% 182.38K to 192.38K | 101% |
| 17-Jan-14 4:21 PM View: | Antares Pharma Inc. (ATRS) | 15-Jan-14 | Option Exercise | 11,400 | $0.50 | $5,700.00 | 9% 126.83K to 138.23K | |
| 17-Jan-14 4:21 PM View: | Antares Pharma Inc. (ATRS) | 15-Jan-14 | Market Option Sale (Planned) | 11,400 | $5.05 | $57,571.10 | (8%) 138.23K to 126.83K | 21% |
| 24-May-13 4:44 PM View: | Antares Pharma Inc. (ATRS) | 22-May-13 | Grant | 55,556 | -- | -- | 44% 126.83K to 182.38K | |
| 21-May-13 4:45 PM View: | Antares Pharma Inc. (ATRS) | 17-May-13 | Market Sale | 17,000 | $4.00 | $68,000.00 | (12%) 143.83K to 126.83K | < 1% |
| 16-Nov-12 2:51 PM View: | Antares Pharma Inc. (ATRS) | 16-Nov-12 | Market Purchase | 10,000 | $3.44 | $34,390.00 | 14% 72.0K to 82.0K | 16% |
| 21-May-12 4:50 PM View: | Antares Pharma Inc. (ATRS) | 17-May-12 | Grant | 61,829 | -- | -- | 86% 72.0K to 133.83K | |
| 22-Dec-11 2:32 PM View: | Antares Pharma Inc. (ATRS) | 22-Dec-11 | Market Purchase | 5,000 | $1.79 | $8,950.00 | 7% 67.0K to 72.0K | 121% |
| 15-Aug-11 2:17 PM View: | Antares Pharma Inc. (ATRS) | 12-Aug-11 | Market Purchase | 2,000 | $2.06 | $4,120.00 | 3% 65.0K to 67.0K | 91% |
| 14-Apr-11 1:56 PM View: | Antares Pharma Inc. (ATRS) | 13-Apr-11 | Market Purchase | 10,000 | $1.58 | $15,840.00 | 18% 55.0K to 65.0K | 149% |
| 17-Aug-10 1:10 PM View: | Antares Pharma Inc. (ATRS) | 16-Aug-10 | Market Purchase | 5,000 | $1.59 | $7,950.00 | 10% 50.0K to 55.0K | 149% |
| 29-Mar-10 8:44 AM View: | Antares Pharma Inc. (ATRS) | 26-Mar-10 | Market Purchase | 5,000 | $1.45 | $7,250.00 | 11% 45.0K to 50.0K | 173% |
| 16-Dec-09 9:59 AM View: | Antares Pharma Inc. (ATRS) | 15-Dec-09 | Market Purchase | 5,000 | $1.07 | $5,350.00 | 12% 40.0K to 45.0K | 270% |
| 19-Nov-08 8:32 AM View: | Antares Pharma Inc. (ATRS) | 17-Nov-08 | Market Purchase | 20,000 | $0.48 | $9,600.00 | 100% 20.0K to 40.0K | 542% |
| 20-Nov-07 4:15 PM View: | Antares Pharma Inc. (ATRS) | 20-Nov-07 | Market Purchase | 5,000 | $1.09 | $5,450.00 | 33% 15.0K to 20.0K | 186% |
| 20-Nov-07 4:15 PM View: | Antares Pharma Inc. (ATRS) | 19-Nov-07 | Market Purchase | 5,000 | $1.09 | $5,450.00 | 50% 10.0K to 15.0K | 186% |
| 22-Aug-07 3:05 PM View: | Antares Pharma Inc. (ATRS) | 20-Aug-07 | Market Purchase | 10,000 | $1.29 | $12,900.00 | 100% 0 to 10.0K | 141% |
| 02-May-07 2:57 PM View: | Bradley Pharmaceuticals Inc (BDY) | 30-Mar-07 | Market Purchase | 1,000 | $19.05 | $19,050.00 | 100% 0 to 1.0K | 5% |
| 04-Oct-05 5:27 PM View: | Inkine Pharmaceutical Co Inc (INKPD.OB) | 30-Sep-05 | Disposition | 390,386 | -- | -- | (100%) 390.39K to 0 | |
| 22-Nov-04 6:24 PM View: | Inkine Pharmaceutical Co Inc (INKPD.OB) | 18-Nov-04 | Grant | 68,136 | -- | -- | 21% 322.25K to 390.39K | |
| 26-Sep-03 10:00 PM View: | Inkine Pharmaceutical Co Inc (INKPD.OB) | 26-Sep-03 | Option Exercise | 319,750 | $0.94 | $300,000.00 | 12790% 2.5K to 322.25K | |
| 24-Sep-03 10:00 PM View: | Inkine Pharmaceutical Co Inc (INKPD.OB) | 24-Sep-03 | Option Exercise | 383,578 | $0.61 | $233,983.00 | 15343% 2.5K to 386.08K |